Hospital of University of Pennsylvania, Division of Nuclear Medicine — Philadelphia, Pennsylvania

Hospital of University of Pennsylvania, Division of Nuclear Medicine is a clinical research site located in Philadelphia, Pennsylvania, United States 19104.

Crixeo Clinical Trials Trust Score: 81/100 (GOOD). This profile has not yet been claimed by the site owner.

Hospital of University of Pennsylvania, Division of Nuclear Medicine has participated in 1 clinical trials.

Therapeutic areas: Solid Tumors.

Sponsors: Mallinckrodt.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Philadelphia

Browse all research sites in Pennsylvania · View every site in Philadelphia

Sponsor Feasibility Report

Trust Score: 81/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Hospital of University of Pennsylvania, Division of Nuclear Medicine?

Hospital of University of Pennsylvania, Division of Nuclear Medicine has a Crixeo Trust Score of 81/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Hospital of University of Pennsylvania, Division of Nuclear Medicine conducted?

Hospital of University of Pennsylvania, Division of Nuclear Medicine has 1 clinical trials on record. Their work covers Solid Tumors.

Is Hospital of University of Pennsylvania, Division of Nuclear Medicine accredited by Crixeo Clinical Trials?

Hospital of University of Pennsylvania, Division of Nuclear Medicine has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Hospital of University of Pennsylvania, Division of Nuclear Medicine?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.